183 related articles for article (PubMed ID: 14694839)
1. [Diabetes mellitus, cardiovascular sequelae and acarbose. Introductory Address by the German Diabetes Society].
Schatz H
Med Klin (Munich); 2003 Oct; 98 Suppl 1():20. PubMed ID: 14694839
[No Abstract] [Full Text] [Related]
2. [Dangerous blood glucose peaks. Vascular damage even before diabetes].
MMW Fortschr Med; 2003 Sep; 145(35-36):53. PubMed ID: 14584214
[No Abstract] [Full Text] [Related]
3. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.
Chiasson JL; Josse RG; Gomis R; Hanefeld M; Karasik A; Laakso M;
JAMA; 2003 Jul; 290(4):486-94. PubMed ID: 12876091
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and early therapy play too minor a role in our health care system].
Rothe HJ
Med Klin (Munich); 2003 Oct; 98 Suppl 1():22-3. PubMed ID: 14694840
[No Abstract] [Full Text] [Related]
5. [Robert Koch Award for acarbose. Antidiabetic drug prevents myocardial infarct].
MMW Fortschr Med; 2003 Feb; 145(6):59. PubMed ID: 12619367
[No Abstract] [Full Text] [Related]
6. [Already in altered glucose tolerance an antidiabetic drug. Significantly fewer heart attacks].
MMW Fortschr Med; 2003 Jan; 145(3-4):57. PubMed ID: 12619238
[No Abstract] [Full Text] [Related]
7. [Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?].
Leschke M
Med Klin (Munich); 2003 Oct; 98 Suppl 1():12-6. PubMed ID: 14694836
[TBL] [Abstract][Full Text] [Related]
8. [Cardioprotection by acarbose--pro].
Breuer HW
Dtsch Med Wochenschr; 2004 May; 129(20):1155. PubMed ID: 15143459
[No Abstract] [Full Text] [Related]
9. [Cardioprotection by acarbose--contra].
Kaiser T; Sawicki PT
Dtsch Med Wochenschr; 2004 May; 129(20):1156. PubMed ID: 15143460
[No Abstract] [Full Text] [Related]
10. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
Laakso M
Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
[No Abstract] [Full Text] [Related]
11. Acarbose for patients with hypertension and impaired glucose tolerance.
Rosenthal JH
JAMA; 2003 Dec; 290(23):3066; author reply 3067-9. PubMed ID: 14679262
[No Abstract] [Full Text] [Related]
12. Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus.
Delorme S; Chiasson JL
Curr Opin Pharmacol; 2005 Apr; 5(2):184-9. PubMed ID: 15780829
[TBL] [Abstract][Full Text] [Related]
13. [How does the PROactive Study change therapy of diabetes?].
Erdmann E
MMW Fortschr Med; 2005 Oct; 147(41):6. PubMed ID: 16270501
[No Abstract] [Full Text] [Related]
14. [Insulin resistance increases risk of infarct. Glitazone now approved also for monotherapy].
MMW Fortschr Med; 2003 Sep; 145(38):61. PubMed ID: 14603688
[No Abstract] [Full Text] [Related]
15. Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes.
Hanefeld M
Cardiovasc Diabetol; 2007 Aug; 6():20. PubMed ID: 17697384
[TBL] [Abstract][Full Text] [Related]
16. Post-prandial hyperglycaemia and prevention of cardiovascular disease.
Davies MJ
Diabet Med; 2005 Jan; 22 Suppl 1():6-9. PubMed ID: 15610148
[No Abstract] [Full Text] [Related]
17. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
MMW Fortschr Med; 2012 Feb; 154(3):82-3. PubMed ID: 22458177
[No Abstract] [Full Text] [Related]
18. Do not forget that type 2 diabetes does not only expose to cardiovascular complications.
Halimi S
Diabetes Metab; 2014 Jun; 40(3):167-8. PubMed ID: 24751987
[No Abstract] [Full Text] [Related]
19. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes.
Zeymer U
Int J Cardiol; 2006 Feb; 107(1):11-20. PubMed ID: 16337493
[TBL] [Abstract][Full Text] [Related]
20. Acarbose for patients with hypertension and impaired glucose tolerance.
Bridges CM
JAMA; 2003 Dec; 290(23):3066-7; author reply 3067-9. PubMed ID: 14679261
[No Abstract] [Full Text] [Related]
[Next] [New Search]